Ceres Power Holdings plc (LON:CWR - Get Free Report) was down 6.1% during mid-day trading on Tuesday . The stock traded as low as GBX 110.30 ($1.49) and last traded at GBX 110.80 ($1.50). Approximately 860,362 shares were traded during mid-day trading, a decline of 42% from the average daily volume of 1,488,002 shares. The stock had previously closed at GBX 118 ($1.59).
Ceres Power Stock Up 1.1%
The company has a debt-to-equity ratio of 1.54, a current ratio of 6.48 and a quick ratio of 12.18. The company has a market cap of £199.43 million, a price-to-earnings ratio of -702.87 and a beta of 1.60. The firm's 50 day simple moving average is GBX 108.20 and its 200-day simple moving average is GBX 81.48.
About Ceres Power
(
Get Free Report)
Ceres is a leading developer of clean energy technology: electrolysis for the creation of green hydrogen and fuel
cells for power generation. Its asset-light, licensing model has seen it establish partnerships with some of the world's largest companies, such as Bosch, Doosan, Delta and Weichai. Ceres' solid oxide technology supports greater electrification of our energy systems and produces green hydrogen at high-efficiencies as a route to decarbonise emissions-intensive industries such as steelmaking, ammonia and future fuels.
Featured Articles
Before you consider Ceres Power, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ceres Power wasn't on the list.
While Ceres Power currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.